Max Jaderberg, President, Isomorphic Labs, discusses how AI is accelerating scientific discovery and opening new approaches to drug development with Bloomberg’s Shirin Ghaffary at the 2026 Bloomberg Tech in London. (Source: Bloomberg)
Max Jaderberg, President, Isomorphic Labs, discusses how AI is accelerating scientific discovery and opening new approaches to drug development with Bloomberg’s Shirin Ghaffary at the 2026 Bloomberg Tech in London. (Source: Bloomberg)
<iframe src="https://statesidedaily.com/embed/cluster/fad74451742d56fc12ec0fc6f13e1c89fc96cdf9" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="How AI Is Changing Drug Discovery at Isomorphic Labs"></iframe>